Pharma

The Direct-to-Patient Platform: Transforming the Patient Journey for Better Outcomes

Matthew Walsh, General Manager of Biopharma at ixlayer - the leading cloud-based platform powering an end-to-end, direct-to-patient healthcare solution - sat down with Fierce at Digital Pharma East.

Walsh tackles some of the most pervasive myths in pharma marketing - starting with the misconception that healthcare is solely targeted at older audiences. Critically, he argues that user-friendly technology will generate engagement from all age groups, sharing anecdotes that illustrate how seniors embrace well-designed digital solutions.

Walsh also explores the exciting rise of direct-to-patient (DTP) services. With over 50% of pharmaceutical marketing executives planning to implement these services, he sheds light on how this shift could revolutionize the way patients interact with healthcare and, critically, simplify the patient journey.

Here, Walsh shares lessons learned from successful initiatives like PfizerforAll and LillyDirect and highlights the need for consistency in approach and technology.

Further, this interview delves into the critical factors that pharma partners should consider when selecting their DTP strategies. Walsh points to the merits a unified platform can offer - from streamlined operations to a better patient experience.

For more on DTP and the future of pharma, tune into this insightful, thought-provoking conversation - perfect for industry veterans and newcomers alike.

The editorial staff had no role in this post's creation.